Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology

• Autori principali: Feng Xu (Autore), Mei Zhang (Autore), Hongmei Wu (Autore), Yuanmin Wang (Autore), Ye Yang (Autore), Xiangpei Wang (Autore)
• Natura: Libro
• Pubblicazione: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Context Lupenone (LUP) is the active ingredient of Musa basjoo Sieb. et Zucc. (Musaceae) with antidiabetes effects, but an unclear underlying mechanism of action.Objective Animal experiments combined with network pharmacology were used to explore the mechanism of LUP for treating diabetes.Materials...